Swedbank
AZN icon

Swedbank’s AstraZeneca AZN Stock Holding History

Swedbank’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$425M Sell
2,241,677
-226,734
-9% -$42.6M 0.37% 59
2026
Q1 		$487M Buy
2,468,411
+473,741
+24% +$91.3M 0.51% 42
2025
Q4 		$367M Sell
1,994,670
-187,559
-9% -$32.9M 0.35% 58
2025
Q3 		$335M Buy
2,182,229
+143,452
+7% +$21.7M 0.34% 61
2025
Q2 		$285M Buy
2,038,777
+350,889
+21% +$49.2M 0.32% 70
2025
Q1 		$248M Buy
1,687,888
+272,209
+19% +$39.4M 0.33% 65
2024
Q4 		$186M Buy
1,415,679
+62,800
+5% +$8.79M 0.23% 91
2024
Q3 		$211M Buy
1,352,879
+17,500
+1% +$2.82M 0.27% 84
2024
Q2 		$208M Sell
1,335,379
-38,250
-3% -$5.76M 0.28% 77
2024
Q1 		$186M Buy
1,373,629
+46,750
+4% +$6.19M 0.26% 80
2023
Q4 		$179M Hold
1,326,879
– – 0.29% 72
2023
Q3 		$180M Hold
1,326,879
– – 0.31% 64
2023
Q2 		$190M Buy
1,326,879
+119,000
+10% +$17.5M 0.32% 63
2023
Q1 		$168M Buy
1,207,879
+100
+0% +$13.5K 0.33% 65
2022
Q4 		$164M Buy
1,207,779
+51,550
+4% +$6.46M 0.36% 59
2022
Q3 		$127M Hold
1,156,229
– – 0.3% 70
2022
Q2 		$153M Buy
1,156,229
+55,710
+5% +$7.31M 0.34% 60
2022
Q1 		$146M Sell
1,100,519
-89,200
-7% -$10.7M 0.27% 84
2021
Q4 		$139M Sell
1,189,719
-105,500
-8% -$12.4M 0.23% 97
2021
Q3 		$156M Buy
+1,295,219
New +$151M 0.29% 69

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Swedbank's AZN Position: Q2 2026 in Review

Swedbank reduced its AstraZeneca (AZN) stake by 9.2% in Q2 2026, selling an estimated $42.6M and leaving 2,241,677 shares worth $425M. The position accounts for 0.37% of the portfolio, ranked #59.

Swedbank first reported a position in AZN in Q3 2021 and has held it in 20 quarters since. The position peaked at $487M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Swedbank held 2,241,677 shares of AstraZeneca worth $425M as of Q2 2026.
  • Swedbank sold 226,734 AstraZeneca shares in Q2 2026, an estimated $42.6M.
  • AstraZeneca made up 0.37% of Swedbank's portfolio in Q2 2026, its #59 holding.
  • Swedbank first reported a position in AstraZeneca in Q3 2021 and has held it in 20 quarters since.
  • Swedbank's AstraZeneca position peaked at $487M in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.